Next Article in Journal / Special Issue
Effects of Exposure to Tobacco Cigarette, Electronic Cigarette and Heated Tobacco Product on Adipocyte Survival and Differentiation In Vitro
Previous Article in Journal
Monosodium Glutamate (MSG)-Induced Male Reproductive Dysfunction: A Mini Review
Previous Article in Special Issue
Electronic Nicotine Delivery Systems (ENDS) and Their Relevance in Oral Health
Open AccessArticle

Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent

1
Laboratory of Organic Analytical Chemistry, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA
2
Department of Environmental Health Sciences, School of Public Health, University at Albany, State University of New York, Rensselaer, NY 12144, USA
3
Laboratory of Molecular Diagnostics, Wadsworth Center, New York State Department of Health, Albany, NY 12201, USA
4
Center for Environmental Health, New York State Department of Health, Albany, NY 12201, USA
5
Albany Medical Center, Department of Pediatrics, Albany, NY 12208, USA
*
Author to whom correspondence should be addressed.
Received: 3 December 2019 / Revised: 15 December 2019 / Accepted: 17 December 2019 / Published: 24 January 2020
(This article belongs to the Special Issue Current knowledge of E-cigarettes and Heated Tobacco Products)
Beginning in June of 2019, there was a marked increase in reported cases of serious pulmonary injury associated with vaping. The condition, referred to as e-cigarette or vaping product use-associated lung injury (EVALI), does not appear to involve an infectious agent; rather, a chemical adulterant or contaminant in vaping fluids is suspected. In August of 2019, the Wadsworth Center began receiving vaporizer cartridges recovered from patients with EVALI for analysis. Having no a priori information of what might be in the cartridges, we employed untargeted analyses using gas chromatography-mass spectrometry and high-resolution mass spectrometry to identify components of concern. Additionally, we employed targeted analyses used for New York medical marijuana products. Here, we report on the analyses of 38 samples from the first 10 New York cases of EVALI for which we obtained cartridges. The illicit fluids had relatively low cannabinoid content, sometimes with unusual Δ9-/Δ8-tetrahydrocannabinol ratios, sometimes containing pesticides and many containing diluents. A notable diluent was α-tocopheryl acetate (vitamin E acetate; VEA), which was found in 64% of the cannabinoid-containing fluids. To investigate potential sources of the VEA, we analyzed six commercial cannabis-oil diluents/thickeners. Three were found to be >95% VEA, two were found to be primarily squalane, and one was primarily α-bisabolol. The cause(s) of EVALI is unknown. VEA and squalane are components of some personal care products; however, there is growing concern that vaping large amounts of these compounds is not safe. View Full-Text
Keywords: electronic cigarettes; vaping cartridges; cannabinoids; vitamin E acetate electronic cigarettes; vaping cartridges; cannabinoids; vitamin E acetate
Show Figures

Graphical abstract

MDPI and ACS Style

Duffy, B.; Li, L.; Lu, S.; Durocher, L.; Dittmar, M.; Delaney-Baldwin, E.; Panawennage, D.; LeMaster, D.; Navarette, K.; Spink, D. Analysis of Cannabinoid-Containing Fluids in Illicit Vaping Cartridges Recovered from Pulmonary Injury Patients: Identification of Vitamin E Acetate as a Major Diluent. Toxics 2020, 8, 8.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop